ONIVYDE (irinotecan liposome injection)
ONIVYDE is a brand-name prescription medication that’s used to treat pancreatic cancer. ONIVYDE (irinotecan liposome injection), for intravenous use Initial U.S. Approval: 1996
Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!
For Overseas Patient/ Export inquires.
Call / WhatsApp Number
+91 9643240915 (Mr. Yashpal Singh)
+91 9289711087 (Ms. Sana Sadyar)
For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.
ONIVYDE (irinotecan liposome injection)
Irinotecan Hydrochloride Liposome, Irinotecan hydrochloride liposome is approved to be used with fluorouracil and leucovorin calcium to treat: Pancreatic cancer.
Onivyde, A form of the anticancer drug irinotecan hydrochloride that is contained inside very tiny, fat-like particles and is used with other drugs to treat pancreatic cancer that has spread to other parts of the body. It is used in patients whose cancer has gotten worse after treatment with gemcitabine hydrochloride. Onivyde may have fewer side effects and work better than other forms of irinotecan hydrochloride. It is also being studied in the treatment of other types of cancer. Onivyde blocks a certain enzyme needed for cell division and DNA repair, and it may kill cancer cells. It is a type of topoisomerase inhibitor and a type of camptothecin analog. Also called irinotecan hydrochloride liposome, liposome-encapsulated irinotecan hydrochloride PEP02, and PEP02.
Irinotecan Hydrochloride Liposome, Irinotecan hydrochloride liposome is approved to be used with fluorouracil and leucovorin calcium to treat: Pancreatic cancer. Irinotecan hydrochloride liposome is also being studied in the treatment of other types of cancer.
Drug (Brand / Generic): ONIVYDE / irinotecan liposome injection
Current Indications: pancreatic cancer
Marketed by:: Merrimack Pharmaceuticals, Inc
Approval Date: 1996
Available as (Form & Strength): Injection: 43 mg/10 mL single dose vial. ONIVYDE is available in a single-dose vial containing 43 mg irinotecan free base at a concentration of 4.3 mg/mL
NDC: 69171-398-01
For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here
Alleviare Life Sciences
About Us
Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.
Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.
Alleviare India is certified pharmaceutical facilitator / supplier / importer based in india. They are also who GDP certified. One of the pharmaceutical products they offer is “ONIVYDE (irinotecan liposome injection)”.
Confirmation of the order for AONIVYDE (irinotecan liposome injection) will be subject to the submission of a valid doctor’s prescription and, if applicable, an import permit.
We have delivered medicines to following cities in India – Ahmedabad, Aizawal, Aurangabad, Barshi, Bengaluru, Bhopal, Cachar, Chennai, Dibrugarh, Hyderabad, Karungapally, Kohima, Kollam, Kolkata, Mumbai, Meghalaya, Mizoram, Sikkim, Nagpur, New Delhi, Pondichery, Pune, Punjab, Thirunananthapuram, Tripura, Wardha
ALS serves as a facilitator, supplier & exporter in India assisting patients, doctors, and hospitals in importing the prescription medicine brand ONIVYDE (irinotecan liposome injection). The import process requires a valid prescription and an Import License in the Patient’s Name.
For patients from following foreign countries seeking access to ONIVYDE (irinotecan liposome injection), they can inquire and find further information by sending their inquiries to ALS.
We have delivered medicines to following countries – Argentina, Australia, Austria, Azerbaijan, Bahrain, Brazil, Bulgaria, Cambodia, Canada, Chile, Colombia, Costa Rica, Croatia, Cyprus, Denmark, Dominican Republic, Estonia, Finland, France, Georgia, Germany, Ghana, Greece, Guatemala, India, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kenya, Kuwait, Latvia, Lebanon, Libya, Lithuania, Malawi, Mexico, Montenegro, Nepal, Netherlands, New Zealand, Nigeria, Norway, Oman, Pakistan, Paraguay, Peru, Poland, Qatar, Romania, Saudi Arabia, Serbia, Singapore, Slovenia, Spain, Sri Lanka, Sweden, Switzerland, United Arab Emirates, United Kingdom, United States, Venezuela, Zimbabwe.
Kindly reach out to us for ONIVYDE (irinotecan liposome injection) price and availability confirmation.
The price of the medicines is the cost set by the manufacturer. In addition, Named Patient support fee, shipping costs and any local tax (if applicable) will apply.
